3-deazaneplanocin has been researched along with Cell Transformation, Neoplastic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, W; Duan, R; Guo, W | 1 |
| Alimova, I; Dubuc, A; Foreman, NK; Harris, P; Marquez, VE; Northcott, PA; Taylor, MD; Venkataraman, S; Vibhakar, R | 1 |
1 review(s) available for 3-deazaneplanocin and Cell Transformation, Neoplastic
| Article | Year |
|---|---|
EZH2: a novel target for cancer treatment.
Topics: Adenosine; Antineoplastic Agents; Benzamides; Biphenyl Compounds; Cell Cycle; Cell Transformation, Neoplastic; Clinical Trials as Topic; Combined Modality Therapy; Drug Resistance, Neoplasm; Enhancer of Zeste Homolog 2 Protein; Epigenetic Repression; Histone Code; Histones; Humans; Methylation; Morpholines; Multicenter Studies as Topic; Neoplasm Metastasis; Neoplasm Proteins; Neoplasms; Polycomb Repressive Complex 2; Pyridones; Structure-Activity Relationship; Transcriptional Activation; Tumor Microenvironment | 2020 |
1 other study(ies) available for 3-deazaneplanocin and Cell Transformation, Neoplastic
| Article | Year |
|---|---|
Targeting the enhancer of zeste homologue 2 in medulloblastoma.
Topics: Adenosine; Adolescent; Apoptosis; Blotting, Western; Case-Control Studies; Cell Cycle; Cell Differentiation; Cell Proliferation; Cell Transformation, Neoplastic; Cerebellar Neoplasms; Cerebellum; Child; Colony-Forming Units Assay; DNA Copy Number Variations; DNA Methylation; DNA-Binding Proteins; Enhancer of Zeste Homolog 2 Protein; Flow Cytometry; Histones; Humans; Luciferases; Medulloblastoma; Neoplastic Stem Cells; Polycomb Repressive Complex 2; RNA, Small Interfering; Spheroids, Cellular; Transcription Factors; Tumor Cells, Cultured | 2012 |